» Articles » PMID: 35281786

Low Hemoglobin is Associated with Worse Outcomes Via Larger Hematoma Volume in Intracerebral Hemorrhage Due to Systemic Disease

Overview
Journal MedComm (2020)
Specialty Health Services
Date 2022 Mar 14
PMID 35281786
Authors
Affiliations
Soon will be listed here.
Abstract

Whether hemoglobin is associated with outcomes of a specific subtype of intracerebral hemorrhage (ICH) is unknown. A total of 4643 patients with ICH from a multicenter cohort were included in the analysis (64.0% male; mean age [SD], 58.3 [15.2] year), of whom 1319 (28.4%) had anemia on admission. The unsupervised consensus cluster method was employed to classify the patients into three clusters. The patients of cluster 3 were characterized by a high frequency of anemia (85.3%) and mainly composed of patients of systemic disease ICH subtype (SD-ICH; 90.0%) according to the SMASH-U etiologies. In SD-ICH, a strong interaction effect was observed between anemia and 3-month death (adjusted odds ratio [aOR] 4.33, 95% confidence interval [CI] 1.60-11.9, = 0.004), and the hemoglobin levels were linearly associated with 3-month death (aOR 0.75, 95% CI 0.60-0.92; = 0.009), which was partially mediated by larger baseline hematoma volume (= 0.008). This study demonstrated a strong linear association between low hemoglobin levels and worse outcomes in SD-ICH, suggesting that hemoglobin-elevating therapy might be extensively needed in a specific subtype of ICH.

Citing Articles

Development of a machine learning model for prediction of intraventricular hemorrhage in premature neonates.

Saeedi E, Mashhadinejad M, Tavallaii A Childs Nerv Syst. 2024; 41(1):51.

PMID: 39680160 DOI: 10.1007/s00381-024-06714-z.


MSCs overexpressing GDNF restores brain structure and neurological function in rats with intracerebral hemorrhage.

Jiang X, Zhou L, Sun Z, Xie B, Lin H, Gao X Mol Biomed. 2023; 4(1):43.

PMID: 38008847 PMC: 10678901. DOI: 10.1186/s43556-023-00159-7.


Low hemoglobin is associated with worse outcomes via larger hematoma volume in intracerebral hemorrhage due to systemic disease.

Zhang S, Shu Y, Chen Y, Liu X, Liu Y, Cheng Y MedComm (2020). 2022; 3(1):e96.

PMID: 35281786 PMC: 8906467. DOI: 10.1002/mco2.96.

References
1.
Ho C, Ho M, Chan P, Hai J, Cheung E, Yeung C . Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control. Stroke. 2014; 46(1):23-30. DOI: 10.1161/STROKEAHA.114.006476. View

2.
Yang X, Li Z, Zhao X, Wang C, Liu L, Wang C . Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China. Stroke. 2015; 47(2):464-70. DOI: 10.1161/STROKEAHA.115.011833. View

3.
Wang C, Yang Z, Wang C, Wang Y, Zhao X, Liu L . Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry. J Stroke Cerebrovasc Dis. 2013; 23(5):1157-63. DOI: 10.1016/j.jstrokecerebrovasdis.2013.10.006. View

4.
Wilkerson M, Hayes D . ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010; 26(12):1572-3. PMC: 2881355. DOI: 10.1093/bioinformatics/btq170. View

5.
Gao Q, Fu X, Wei J, Chen X, Huang Y, Wang J . Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study. Int J Stroke. 2011; 8(3):150-4. DOI: 10.1111/j.1747-4949.2011.00716.x. View